clinical trial | Q30612 |
P3098 | ClinicalTrials.gov ID | NCT04302402 |
P6099 | clinical trial phase | phase II clinical trial | Q42824440 |
P17 | country | India | Q668 |
P582 | end time | 2021-03-01 | |
P4135 | maximum age | 65 | |
P2899 | minimum age | 18 | |
P1132 | number of participants | 132 | |
P4844 | research intervention | rifaximin | Q416073 |
P859 | sponsor | Sanjay Gandhi Post Graduate Institute of Medical Sciences | Q7418428 |
P580 | start time | 2020-03-01 | |
P8363 | study type | interventional study | Q78089383 |
P1476 | title | Multi-dimensional Clinical and Pathophysiological Profiles of Patients With Functional Dyspepsia and Effect of Gut Microbiota Manipulation Using Rifaximin for Its Treatment: A Randomized Controlled Trial |
Search more.